35 results on '"Heney, N.M."'
Search Results
2. The value of external beam radiation in node positive prostate cancer: a multivariate analysis
3. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder
4. The Natural History of Nonmuscle-Invasive Bladder Cancer Recurrences After Complete Response to Combined-Modality Organ-Preserving Therapy for Muscle-Invasive Bladder Cancer
5. Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA
6. Long-term Outcomes After Bladder-Preserving Combined Modality Therapy for Patients With Muscle-Invasive Bladder Cancer
7. Multimodality Management in Primary Urethral Cancer: The Role of Radiation Therapy
8. Long-term Outcomes After Bladder Preserving Combined Modality Therapy for Muscle-invasive Bladder Cancer: A Pooled Analysis of RTOG 8802, 8903, 9506, 9706, 9906, and 0233
9. Nomogram for Predicting Risk of Cystectomy or Recurrence after Bladder Preserving Trimodality Therapy for Muscle Invasive Bladder Cancer
10. Initial Report of RTOG 9601: A Phase III Trial in Prostate Cancer: Anti-androgen Therapy (AAT) with Bicalutamide during and after Radiation Therapy (RT) Improves Freedom from Progression and Reduces the Incidence of Metastatic Disease in Patients following Radical Prostatectomy (RP) with pT2-3, N0 Disease, and Elevated PSA Levels
11. Fifteen-year Outcomes of Selective Bladder Preservation by Combined Modality Therapy for Invasive Bladder Cancer: The Long-term MGH Experience
12. Defining Biochemical Control After Prostate Brachytherapy: Can We Use a Target PSA?
13. Organ conservation as an alternative to radical cystectomy for invasive bladder cancer: urodynamic and quality of life evaluation of patients treated by trimodality therapy
14. RTOG 9706: initial report of a phase I/II trial of bladder-conservation employing TURB, accelerated irradiation sensitized with Cisplatin followed by adjuvant MCV chemotherapy
15. Selective bladder preservation by combined modality treatment of invasive bladder cancer: 10-Year outcome
16. Phase III Trial of Neoadjuvant Chemotherapy in Patients With Invasive Bladder Cancer Treated With Selective Bladder Preservation by Combined Radiation Therapy and Chemotherapy: Initial Results of Radiation Therapy Oncology Group 89-03
17. A PHASE I/II TRIAL OF TRANSURETHRAL SURGERY COMBINED WITH CONCURRENT CISPLATIN, 5-FLUOROURACIL AND TWICE DAILY RADIATION FOLLOWED BY SELECTIVE BLADDER PRESERVATION IN OPERABLE PATIENTS WITH MUSCLE INVADING BLADDER CANCER
18. 41 : A Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy
19. 42 A phase trial of transurethral surgery plus cisplatin and radiation therapy followed by either selective bladder preservation or radical cystectomy for patients with muscle-invading bladder cancer but without hydronephrosis
20. 1141 Selective bladder preservation by combined modality therapy for invasive bladder cancer
21. 2018 Selective bladder preservation by combined modality therapy for invasive bladder cancer
22. 1016 Biochemical outcome following external beain radiation therapy for T1–2 prostate carcinoma: the importance of achieving an undetectable nadir PSA
23. 7 Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer
24. Results of a randomized trial of total radiation for stage T3-T4 prostate cancer boosting with photons (to 67.2 cge) or with conformal protons (to 75.6 CGE)
25. Case 33-1992
26. Post-irradiation biopsy of the prostate in stage T3 prostatc cancer: Correlation with original histologic grade and with current PSA values
27. First-Line Chemotherapy of Superficial Bladder Cancer: Mitomycin vs Thiotepa
28. Biopsy of Apparently Normal Urothelium in Patients with Bladder Carcinoma
29. Ileal conduit hemorrhage secondary to portal hypertension
30. Positive Urinary Cytology in Patients without Evident Tumor
31. Mitomycin for Patients Who Have Failed on Thiotepa
32. Invasive bladder cancer: MCV (methotrexate, cisplatin, vinblastine) followed by cisplatin plus pelvic irradiation and possible cystectomy: Patient tolerance and local tumor response
33. The Renal Lymphatic System During Obstructed Urine Flow
34. Combined modality therapy as a means of blandder preservation for invasive bladder cancer
35. Autosuturing device in intestinal urinary conduits
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.